# Normobaric Hyperoxia Combined With Reperfusion for Acute Ischemic Stroke

> **NCT03620370** · NA · COMPLETED · sponsor: **Capital Medical University** · enrollment: 86 (actual)

## Conditions studied

- Stroke, Acute

## Interventions

- **DRUG:** Normobaric oxygen therapy

## Key facts

- **NCT ID:** NCT03620370
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-12
- **Primary completion:** 2019-07-21
- **Final completion:** 2019-10-19
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2023-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03620370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03620370, "Normobaric Hyperoxia Combined With Reperfusion for Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03620370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*